QUANTUM announced on August 5, 2025, from Toronto, that their CSR allowed the advancement of an IND application with the FDA.

The entities involved

• QUANTUM →

  Nothing else this week.

• FDA →
  • Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
  • A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56

Related events

• The FDA appointed Patrizia Cavazzoni to the permanent director role of the Center for Biologics Evaluation and Research (CBER).Sep 9
• The FDA placed a clinical hold on the IND application for the company Aardvark.Jul 30
• A study protocol involving a company based in Mont-Saint-Guibert was approved by the U.S. FDA.Sep 2
• FDA approval enables commercial opportunity involving CBRE Group.Sep 17
• Atrium and Bristol-Myers Squibb received IND clearance from the FDA and obtained a No Objection Letter for Canadian sites.Sep 6